 Aalberts: patent litigations concluded
Effective on Thursday, DSI - Dispense Systems International B.V., a wholly owned daughter company of Aalberts Industries N.V. - and Micro Matic have settled unanimously all patent disputes. Both parties are entitled to use the litigious patents independently. Thereby, the dispute between the companies DSI and Micro Matic has come to an end.
profile
Airspray joins forces with TricorBraun
Airspray has reached a distribution agreement with TricorBraun, the largest packaging distributor in the USA. TricorBraun, with 26 offices throughout the USA, will increase Airspray's market presence, especially at the small and mid-size accounts. The Airspray sales organisation will continue to serve the existing customer base and will work together with TricorBraun representatives to increase penetration. Airspray has, in order to realise a better penetration and coverage of the medium and small sized sales accounts, reached a distribution agreement with TricorBraun, the largest packaging distributor in the United States.
profile
Corus and Sumitomo agree technical collaboration
Corus and Sumitomo Metals have signed an agreement for technical collaboration in areas of mutual interest and benefit. Initial exchanges will focus on advanced steels for the automotive and engineering industries. The main objectives of the agreement are to exchange ideas and experience to bring about research, development and manufacturing efficiency improvements and to respond more effectively to customers' needs. This will be achieved through an effective combination and sharing of respective technical and service capabilities and by taking advantage of the combined global presence. This will also provide an opportunity to respond with greater effectiveness to growing demands from major customers, such as automotive companies, for the global sourcing of high quality steels to support global solutions.
profile
|
Crucell enters into license agreement with Molelecular Medicine
Dutch antibody and vaccine company Crucell on Thursday announced that it entered into a license agreement with San Diego-based Molecular Medicine, LLC to offer manufacturing services for clinical grade materials on Crucell's proprietary PER.C6 technology in the US. Under the terms of the agreement, Crucell will receive upfront and annual payments, as well as double-digit royalties on sales. Further financial details were not disclosed. "This deal will meet the increasing need of the market for PER.C6 manufacturing services for vaccine and gene therapy products" said Crucell's CEO Dinko Valerio.
profile
Philips CEO outlines vision for reshaping Philips in 2002 and beyond
Gerard Kleisterlee, President and Chief Executive Officer of Royal Philips Electronics on Thursday expressed his ambition to further increase the focus on reshaping Philips during 2002 and beyond, and building the technology core of the company around displays, connectivity and storage. Mr. Kleisterlee was giving a keynote speech at the Consumer Electronics Show in Las Vegas, the first ever Philips executive to do so. "It is our goal for the year 2002 to transform Philips into a high-growth technology company that creates market leadership and high growth by improving peoples' interaction with meaningful technology, thereby enhancing the quality of their lives", stated Mr.
profile
|
